Medtronic Business Summary скачать в хорошем качестве

Medtronic Business Summary

Medtronic is a leading medical device and health technologies company that designs, manufactures, and markets devices and therapies for cardiovascular, neuroscience, medical‑surgical, and diabetes care, with operations in over 150 countries. In its most recent quarter (Q1 FY26), the company posted about $8.58 billion in revenue, growing ~8.4% year‑over‑year (4.8% organic), with its largest segment — Cardiovascular — generating roughly $3.29 billion. Medtronic also saw strong growth in its Diabetes business (≈11.5% reported, ~7.9% organic) and solid performance in Neuroscience and Medical Surgical, though the latter lags a bit behind in growth. The company’s revenue model depends largely on sales of high‑margin implanted devices and therapies (especially heart devices), supported by recurring consumables/services, software, and after‑sales support. Its customer base includes hospitals, clinics, specialized physicians (e.g. cardiologists, neurologists, surgeons), patients with chronic conditions (like diabetes or heart failure), and healthcare systems requiring monitoring and surgical equipment. Medtronic’s main competitors in the device space include Abbott Laboratories, Boston Scientific, Johnson & Johnson, Stryker, and Siemens Healthineers.